| Patient | Christopher Reeve |
|---|---|
| Date of birth | 1975-09-25 |
| Identifiers | MRN HR-ML024-SYN; SSN (made up) 000-24-7765 |
| Document date | 2026-08-24 |
| Author | Teresa Galloway, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Four-month review: kidney function, skin, mood, and equipment. [S]
Mr. Reeve returns two months after his last review. He now uses the pacer for three hours twice a day. The seating service saw him three weeks ago through a second provider: pressure mapping showed higher pressure under the left sitting bone, and his cushion was adjusted; repeat mapping after the change was even. His skin has stayed intact. He has had no symptoms of autonomic dysreflexia, and his bladder and bowel programs are working. His mood is good and he is busy with his advocacy work. [S]
| Element | Detail |
|---|---|
| Breathing | Pacer three hours twice a day |
| Seating | Pressure mapping done; cushion adjusted for higher left ischial pressure |
| Skin | Intact |
| Mood | Good; PHQ-9 2 |
| System | Result | Finding |
|---|---|---|
| Respiratory | Negative | No fever or change in secretions |
| Cardiovascular | Negative | No pounding headaches or flushing; no leg swelling |
| Genitourinary | Negative | Catheter draining well |
| Integumentary | Negative | No lasting redness |
| Psychiatric | Negative | Mood good |
5 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Sennosides 8.6 mg oral tablet, two tablets at bedtime | Two tablets at bedtime | Oral route | 2026-04-13 | active | S |
| Nitroglycerin 2% ointment, one inch to the skin of the chest only if systolic blood pressure stays at 150 mmHg or higher after the first steps of the autonomic dysreflexia plan; wipe off when pressure falls | As needed for autonomic dysreflexia, under the written plan | Topical route | 2026-04-13 | active | S |
| Acetaminophen 500 mg oral tablet, two tablets up to three times a day as needed for neck and shoulder aching | Two tablets up to three times a day as needed | Oral route | 2026-04-13 | active | S |
| Cholecalciferol (vitamin D3) 2000 units (50 mcg) oral capsule, one capsule daily | One capsule daily | Oral route | 2026-04-27 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-08-24 | Body height | 193 | cm | S |
| 2026-08-24 | Body weight | 82.8 | kg | S |
| 2026-08-24 | Body mass index (BMI) [Ratio] | 22.2 | kg/m2 | S |
| 2026-08-24 | Systolic blood pressure | 104 | mm[Hg] | S |
| 2026-08-24 | Diastolic blood pressure | 66 | mm[Hg] | S |
| 2026-08-24 | Heart rate | 62 | /min | S |
| 2026-08-24 | Respiratory rate | 12 | /min | S |
| 2026-08-24 | Body temperature | 36.4 | Cel | S |
| 2026-08-24 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-08-24 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-08-24 | Potassium [Moles/volume] in Serum or Plasma | 4.3 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-08-24 | Creatinine [Mass/volume] in Serum or Plasma | 0.5 | mg/dL | 0.74-1.35 mg/dL | Low | S |
| 2026-08-24 | Cystatin C [Mass/volume] in Serum or Plasma | 0.9 | mg/L | 0.53-0.95 mg/L | Normal | S |
| 2026-08-24 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Cystatin C-based formula/1.73 sq M | 93 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-08-24 | Braden scale total score | 12 | {score} | S | ||
| 2026-08-24 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 2 | {score} | S |
Vital signs recorded on 2026-08-24; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; blood pressure 104/66, pulse 62 |
| Respiratory | On the pacer with saturation 97%; clear |
| Skin | Intact, including the left ischium; Braden score 12 |
| Extremities | No leg swelling |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Chronic incomplete C2 tetraplegia (ASIA grade C) from a traumatic spinal cord injury in a riding fall eight years ago, with partial late recovery of sensation and movement; uses a power wheelchair and has 24-hour nursing support; at risk of autonomic dysreflexia; synthetic modern episode linked to his documented injury and his physicians' published report | active | confirmed | G82.52 | S — Synthetic modern coding of the documented injury and the published ASIA grade. |
| Chronic ventilatory failure from the high cervical injury: dependent on a ventilator through a tracheostomy, with a diaphragm pacing system implanted some weeks ago and a conditioning program to lengthen time on the pacer; synthetic modern episode linked to his documented ventilator use and pacing | active | confirmed | Z99.11 | S — Synthetic modern coding of the documented ventilator dependence. |
| Neurogenic bladder after spinal cord injury, managed with an indwelling catheter | active | confirmed | N31.9 | S — Synthetic; expected with this level of injury. No public source describes his bladder care. |
| Neurogenic bowel after spinal cord injury, managed with a daily morning bowel program | active | confirmed | K59.2 | S — Synthetic; expected with this level of injury. No public source describes his bowel care. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Autonomic dysreflexia: episodes, baseline blood pressure, written plan, and nurse training | Every visit | Completed today | No episodes |
| Survey | Skin check and Braden scale | Every visit | Completed today | Intact; Braden 12 |
| Self-management | Seating, cushion, and pressure mapping | At least yearly and after any change in equipment, weight or skin | Completed today | Pressure mapping done three weeks ago through a second provider; cushion adjusted for higher left ischial pressure; repeat mapping even |
| Self-management | Catheter care and urinary symptoms | Every visit | Completed today | No symptoms |
| Laboratory | Kidney function (cystatin C; creatinine unreliable with low muscle mass) | At baseline, then every 6 to 12 months | Completed today | Cystatin C 0.90 mg/L, eGFR 93; sodium 139, potassium 4.3 mmol/L; creatinine 0.50 mg/dL |
| Self-management | Bowel program | Every visit | Completed today | Effective |
| Examination | Pacer conditioning, oxygen saturation, and secretion clearance | Every visit | Completed today | Pacer three hours twice a day; saturation 97% on the pacer |
| Self-management | Backup ventilator, suction, cough-assist device, and power plan | Every visit, with monthly checks by his nurses | Completed today | Checks up to date; generator serviced |
| Survey | Depression screen (PHQ-9) | At intake, then every 6 to 12 months and with any change | Completed today | PHQ-9 2 |
| Examination | Venous thromboembolism: leg swelling | Every visit; prophylaxis only during acute illness, surgery or immobilization | Completed today | No leg swelling |
Goal progress:
Guideline basis: Evaluation and Management of Autonomic Dysreflexia and Other Autonomic Dysfunctions: Preventing the Highs and Lows (Consortium for Spinal Cord Medicine) (2021); Pressure Ulcer Prevention and Treatment Following Spinal Cord Injury: A Clinical Practice Guideline for Health-Care Providers, Second Edition (Consortium for Spinal Cord Medicine) (2014); Bladder management for adults with spinal cord injury: a clinical practice guideline for health-care providers (Consortium for Spinal Cord Medicine) (2006); The AUA/SUFU Guideline on Adult Neurogenic Lower Urinary Tract Dysfunction: Treatment and Follow-up (2021); Management of Neurogenic Bowel Dysfunction in Adults after Spinal Cord Injury: Clinical Practice Guideline for Health Care Providers (Consortium for Spinal Cord Medicine) (2021); Respiratory management following spinal cord injury: a clinical practice guideline for health-care professionals (Consortium for Spinal Cord Medicine) (2005); Management of Mental Health Disorders, Substance Use Disorders, and Suicide in Adults with Spinal Cord Injury: Clinical Practice Guideline for Healthcare Providers (Consortium for Spinal Cord Medicine) (2021); Prevention of Venous Thromboembolism in Individuals with Spinal Cord Injury: Clinical Practice Guidelines for Health Care Providers, 3rd ed. (Consortium for Spinal Cord Medicine) (2016)
Follow-up: Preventive visit in three weeks for vaccines. Six-month review in two months. Next scheduled visit 2026-09-14: periodic adult preventive visit. [S]